title: [Adenocarcinoma of the prostate: pathological stage C. 2: Treatment].
abstract: The discovery of a pathological stage C after radical prostatectomy with a curative aim for a clinically localized cancer of the prostate raises the question of a possible adjuvant therapy. The indications and modalities of such a therapy still remain controversial. Our review sums up our knowledge and uncertainties on this point.
authors.affiliation: Clinique Urologique, Hôpital Cochin, Paris.
authors.forename: T
authors.initials: T
authors.lastname: Flam
authors.forename: M
authors.initials: M
authors.lastname: Zerbib
authors.forename: A
authors.initials: A
authors.lastname: Steg
authors.forename: B
authors.initials: B
authors.lastname: Debré
mesh_terms: D000230:Adenocarcinoma / Q000276:immunology / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D000328:Adult; D000951:Antigens, Neoplasm / Q000276:immunology; D003131:Combined Modality Therapy; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D009364:Neoplasm Recurrence, Local; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000276:immunology / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery
chemical_list: D000951:Antigens, Neoplasm
vernacular_title: Adénocarcinome prostatique: le stade C pathologique. Seconde partie: traitement.